• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • Webinars
  • Cisema Webinars: How to Submit a Drug Master Filing (DMF) of API, Excipients & Packaging to China NMPA

Cisema Webinars: How to Submit a Drug Master Filing (DMF) of API, Excipients & Packaging to China NMPA

Friday, 25 March 2022 / Published in Webinars

Cisema Webinars: How to Submit a Drug Master Filing (DMF) of API, Excipients & Packaging to China NMPA

Cisema is delighted to hold a Masterclass with Regulatory Affairs Professionals Society (RAPS) on April 7, 2022. The 2-hour live broadcast will provide an overview and details of drug master files (DMF) for active pharmaceutical ingredients (APIs), excipients and packaging materials (or AEP) for China NMPA.

Webinar: How to Submit a Drug Master Filing (DMF) of API, Excipients & Packaging to China NMPA

Thursday, 07 April 2022 (8:00 AM) – Thursday, 07 April 2022 (10:00 AM) Eastern Time (US & Canada)

China has opportunities to improve alignment with other countries’ more established regulatory systems, and the introduction of the DMF system is a major step towards alignment with global pharmaceutical regulatory standards. It has similarities with the US FDA procedure but there are subtle differences, which this program will examine in detail.

Learning Objectives

After this program, participants will:

  • Understand the key regulations and process of China NMPA drug master filing.
  • Know the key components of the DMF filing structure.
  • Know best practices regarding DMF dossier content.
  • Have a thorough understanding of how to apply for and obtain a China DMF number.
  • Who Should Attend?
  • By attending this program, regulatory professionals and overseas manufacturers will gain a thorough understanding of China DMF and better position themselves to meet the new requirements in China.

Agenda

  • Filing scope & overview
  • Types of approvals
  • NMPA Legal Agent
  • Comparison: China, US & EU
  • Post-approval matters
  • The agenda may vary based on changing requirements.

Presenters

Guo Ning

General Manager Cisema Beijing

Guo Ning is an industry executive with degrees from Nankai University Tianjin (China) and University of Mannheim (Germany) who has developed a deep expertise in China market access issues via his experiences in industry, as a project manager at an import/export business, and as a technical compliance and product safety expert with Cisema for over 15 years.

Hamish King

COO of Cisema Group

Hamish King is COO at Cisema and is admitted as a lawyer in Hong Kong and in New South Wales, Australia and formerly with Magic Circle firm Linklaters in Hong Kong. He lives regularly writes and presents on China regulatory affairs life sciences topics.

Contact Cisema if you would like to learn more about the event or register here.

Tagged under: DMF, Drug Master Filing

What you can read next

China healthcare market update
China healthcare market update webinar – 2021 report
avoid animal testing in Chinaweb-2023
How to avoid animal testing in China for cosmetics | Cisema Webinar
china compulsory certificate
Cisema Webinar: Certification in China – China Compulsory Certificate (CCC)

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • laser therapy devices

    Clinical evaluation of laser therapy devices – New guidelines issued

    Clinical evaluation of laser therapy devices ha...
  • dental implant system

    Clinical evaluation of dental implant systems in China – New guidelines issued

    Clinical evaluation of dental implant system ha...
  • China Medical Device Webinar

    China Medical Device Webinar with AdvaMed Accel for U.S. exporters

    The China Medical Device Webinar will be featur...
  • webinar_medical-device-market-authorisation

    Cisema presenting at FORUM Institut: Medical device marketing authorisation for advanced – Masterclass China

    Cisema is delighted to hold a Masterclass with ...
  • generative AI services

    China’s generative AI interim measures now in effect

    China’s generative AI interim measures fo...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP